2023 Senate Bill 133 / Public Act 313

Health: controlled substances; overdose fatality review act; create.

An act to provide for the review and prevention of deaths from drug overdose in this state; to allow for the creation of overdose fatality review teams; to provide for the powers and duties of the overdose fatality review teams; to regulate certain entities; to prescribe powers and duties of certain state and local governmental officers and entities; and to prescribe remedies for a violation of this act.

House Fiscal Agency Analysis

Senate Bill 133 would create a new act, the Overdose Fatality Review Act, which would allow a county, or a group of counties, to establish an overdose fatality review team to do all of the following with the goal of reducing or preventing drug overdoses and drug overdose fatalities.

Introduced in the Senate

March 2, 2023

Introduced by Sen. Sean McCann (D-19) and 12 co-sponsors

Co-sponsored by Sens. Michael Webber (R-9), Joseph Bellino (R-16), Sylvia Santana (D-2), Stephanie Chang (D-3), Mallory McMorrow (D-8), Rosemary Bayer (D-13), Dayna Polehanki (D-5), Erika Geiss (D-1), Sue Shink (D-14), Sam Singh (D-28), Veronica Klinefelt (D-11) and Mary Cavanagh (D-6)

Referred to the Committee on Health Policy

Sept. 27, 2023

Reported with substitute S-1

Sept. 28, 2023

Referred to the Committee of the Whole

Oct. 5, 2023

Reported with substitute S-1

Substitute S-1 concurred in by voice vote

Oct. 10, 2023

Passed in the Senate 38 to 0 (details)

Received in the House

Oct. 10, 2023

Referred to the Committee on Health Policy

Nov. 2, 2023

Reported without amendment

Nov. 8, 2023

Passed in the House 69 to 40 (details)

Motion to give immediate effect by Rep. Abraham Aiyash (D-9)

The motion prevailed by voice vote

Signed by Gov. Gretchen Whitmer

Dec. 14, 2023